Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value ($000): $116,948 (100.0% shares, 0.0% debt)

Holdings (16)

— Abeona Therapeutics Inc 34.4%

Value ($000) $40,234 Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Biohaven Pharmactl Hldg Co L 25.8%

Value ($000) $30,150 Shares 807,224 Est. Cost $25.00 Unrealized —

— Corbus Pharmaceuticals HLDGS 22.9%

Value ($000) $26,733 Shares 3,738,925 Est. Cost $4.33 Unrealized —

— Vascular Biogenics LTD 4.5%

Value ($000) $5,250 Shares 860,605 Est. Cost $4.61 Unrealized —

AVXL Anavex Life Sciences Corp 2.6%

Value ($000) $2,998 Shares 724,205 Est. Cost $3.56 Unrealized +24.8%

KRYS Krystal Biotech Inc 2.6%

Value ($000) $2,991 Shares 300,000 Est. Cost $10.08 Unrealized 0.0%

— Ampio Pharmaceuticals Inc. 1.4%

Value ($000) $1,609 Shares 2,595,484 Est. Cost $6.03 Unrealized —

— Keryx Biopharmaceuticals Inc. 1.2%

Value ($000) $1,420 Shares 200,000 Est. Cost $10.21 Unrealized —

VNRX Volition RX LTD 1.1%

Value ($000) $1,242 Shares 461,538 Est. Cost $3.75 Unrealized -21.8%

— Summit Therapeutics PLC 1.0%

Value ($000) $1,152 Shares 91,800 Est. Cost $13.27 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.8%

Value ($000) $893 Shares 124,096 Est. Cost $10.20 Unrealized -48.8%

— Alcobra Ltd 0.7%

Value ($000) $812 Shares 804,049 Est. Cost $6.71 Unrealized —

— Evoke Pharma Inc 0.6%

Value ($000) $752 Shares 225,000 Est. Cost $3.16 Unrealized —

— Caladrius Biosciences Inc 0.4%

Value ($000) $422 Shares 117,957 Est. Cost $3.99 Unrealized —

— Advaxis Inc. 0.2%

Value ($000) $191 Shares 112,500 Est. Cost $3.96 Unrealized —

— Lipocine Inc New 0.1%

Value ($000) $99 Shares 25,000 Est. Cost $4.04 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Abeona Therapeutics Inc	2,359,767	$40,234	34.4%	$4.97	—	COM	00289Y107
—	Biohaven Pharmactl Hldg Co L	807,224	$30,150	25.8%	$25.00	—	COM	G11196105
—	Corbus Pharmaceuticals HLDGS	3,738,925	$26,733	22.9%	$4.33	—	COM	21833P103
—	Vascular Biogenics LTD	860,605	$5,250	4.5%	$4.61	—	COM	M96883109
AVXL	Anavex Life Sciences Corp	724,205	$2,998	2.6%	$3.56	+24.8%	COM NEW	032797300
KRYS	Krystal Biotech Inc	300,000	$2,991	2.6%	$10.08	0.0%	COM	501147102
—	Ampio Pharmaceuticals Inc.	2,595,484	$1,609	1.4%	$6.03	—	COM	03209T109
—	Keryx Biopharmaceuticals Inc.	200,000	$1,420	1.2%	$10.21	—	COM	492515101
VNRX	Volition RX LTD	461,538	$1,242	1.1%	$3.75	-21.8%	COM	928661107
—	Summit Therapeutics PLC	91,800	$1,152	1.0%	$13.27	—	SPONS ADS	86627R102
ALDX	Aldeyra Therapeutics Inc	124,096	$893	0.8%	$10.20	-48.8%	COM	01438T106
—	Alcobra Ltd	804,049	$812	0.7%	$6.71	—	SHS	M2239P109
—	Evoke Pharma Inc	225,000	$752	0.6%	$3.16	—	COM	30049G104
—	Caladrius Biosciences Inc	117,957	$422	0.4%	$3.99	—	COM NEW	128058203
—	Advaxis Inc.	112,500	$191	0.2%	$3.96	—	W EXP 07/15/201	007624117
—	Lipocine Inc New	25,000	$99	0.1%	$4.04	—	COM	53630X104